We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Methods Assessed for Detecting Asymptomatic Malaria

By LabMedica International staff writers
Posted on 03 May 2017
Print article
Image: The ABI 7500 Fast Dx real-time PCR instrument (Photo courtesy of Applied Biosystems).
Image: The ABI 7500 Fast Dx real-time PCR instrument (Photo courtesy of Applied Biosystems).
Asymptomatic malaria infection refers to malarial parasitemia of any density in the absence of fever or other acute symptoms in individuals who have not received recent antimalarial treatments.

Sensitive methods for detecting asymptomatic malaria infections are essential for identifying potential transmission reservoirs and obtaining an accurate assessment of malaria epidemiology in low-endemicity areas aiming to eliminate malaria. Polymerase chain reaction (PCR) techniques to detect parasite nucleic acids (DNA or RNA) are among the most commonly used molecular methods.

Scientists at China Medical University and their colleagues recruited 1,005 healthy individuals (344 males and 661 females, ages 1–82 years) living in Kachin Sate, Myanmar between May and November, 2015. Two fingerprick samples were taken, one was processed in a nearby field laboratory, and the other on filter paper, dried and stored. The study compared three molecular detection methods side-by-side, namely nested PCR targeting the ribosomal ribonucleic acid (rRNA) genes, nested RT-PCR to detect parasite rRNA, and capture and ligation probe-PCR (CLIP-PCR) to detect parasite RNA.

Thick and thin blood films stained with Giemsa were prepared and read. For positive slides, parasite density was quantified in 500 white blood cells (WBCs) on thick blood films assuming that 1 µL of blood contains 8,000 WBCs. Total RNA and genomic DNA were extracted from peripheral blood samples. Modified nested PCR (nD-PCR) was performed based on the 18S rRNA gene. For the CLIP-PCR 3-mm circle of dried blood spot on 3 M Whatman filter paper was punched out and lysed with 100-µL lysis mixture. Two RT-PCR methods were used to detect Plasmodium vivax gametocytes in samples. For detection of P. vivax gametocytes in all 1,005 samples, the 645 bp full-length Pvs25 gene was amplified using Pvs25-specific primers. Amplification and detection were performed on an ABI 7500 apparatus.

Light microscopy detected Plasmodium infections in only 1.19% of the residents harboring the parasites. CLIP-PCR had slightly better performance and detected Plasmodium infections in 1.89% of the population. Further improvement was achieved by nested PCR to detect parasite DNA, which detected P. vivax and P. falciparum infections in 2.39% of the residents. The nested RT-PCR targeting rRNA, however, detected as many as 187 (18.61%) individuals having Plasmodium infections with P. vivax being the predominant species (176 P. vivax, five P. falciparum and six P. falciparum/P. vivax mixed infections). Of the 210 Plasmodium-positive samples detected by all molecular methods, 115 were Pvs25-positive by quantitative polymerase chain reaction (qRT-PCR), indicating that a large proportion of asymptomatic individuals were gametocyte carriers.

The authors concluded that Nested RT-PCR based on the detection of asexual-stage parasite rRNA was the most sensitive, with a more than six-fold higher sensitivity than the other two molecular methods of parasite detection. CLIP-PCR has an increased throughput, but its sensitivity in this study was much lower than those of other molecular methods. The study was published on April 20, 2017, in the Malaria Journal.

Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Myeloperoxidase Assay
IDK MPO ELISA
New
Immunofluorescence Analyzer
MPQuanti

Print article

Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Deliver Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.